Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq.
Al-Diwanyah Health Directorate, Al-Diwanyah, Iraq.
J Med Life. 2022 Dec;15(12):1553-1562. doi: 10.25122/jml-2021-0227.
Cyclosporine A (CsA), a well-known immunosuppressive drug, has been prescribed after organ transplantation and in a variety of disorders with an immunological origin. Nephrotoxicity is one of the most frequently stated problems associated with CsA, and therefore the treatment with CsA remains a big challenge. This study sets out to assess the ameliorative influences of Candesartan Cilexetil (CC) on oxidative stress and the nephrotoxic effect of CsA in a rat model. Twenty-four Wister Albino rats, 7-8-week-old, weighing 150-250g, were randomly categorized into three groups (eight animals in each group). These groups were the (1) CsA-treated group, (2) vehicle-treated group, and (3) CC-treated group. Bodyweights were assessed at the start and end of experiments. Renal function test and levels of glutathione peroxidase 1 catalase -CAT (Gpx1), catalase (CAT), superoxide dismutase (SOD), interleukin -2 (IL-2), and malondialdehyde (MDA) were investigated in renal tissues. Histological changes in kidneys were also evaluated. Data showed that levels of urea and creatinine in serum and levels of IL-2 and MDA in renal tissues were elevated in the CsA-treated group, with severe histological changes compared with the control group. Furthermore, tissue levels of Gpx1, CAT, and SOD were significantly decreased in CsA-treated in comparison with the control group. Treatment with CC for the rats subjected to CSA resulted in a marked reduction in levels of serum urea and creatinine and tissue levels of IL-2 and MDA. Levels of Gpx1, CAT, and SOD in renal tissues were greater in the CC-treatment group compared with the CsA-treated group. CC treatment reduced the deterioration of renal morphology compared with CsA treatment. The findings of this study suggest that CC could prevent CSA-induced nephrotoxicity through its anti-inflammatory and antioxidant influences. Considerably more work needs to be done to determine the mechanistic insight behind the ameliorative effect of CC.
环孢素 A(CsA)是一种著名的免疫抑制剂,已在器官移植后和多种免疫源性疾病中使用。肾毒性是与 CsA 相关的最常见问题之一,因此 CsA 的治疗仍然是一个巨大的挑战。本研究旨在评估坎地沙坦西酯(CC)对 CsA 在大鼠模型中氧化应激和肾毒性的改善作用。将 24 只 7-8 周龄、体重 150-250g 的 Wister 白化大鼠随机分为三组(每组 8 只)。这些组是(1)CsA 处理组、(2)载体处理组和(3)CC 处理组。在实验开始和结束时评估体重。研究了肾脏组织中谷胱甘肽过氧化物酶 1 过氧化氢酶 -CAT(Gpx1)、过氧化氢酶(CAT)、超氧化物歧化酶(SOD)、白细胞介素 -2(IL-2)和丙二醛(MDA)的水平以及肾脏的组织学变化。数据显示,与对照组相比,CsA 处理组血清中尿素和肌酐水平以及肾组织中 IL-2 和 MDA 水平升高,且与对照组相比,组织中 Gpx1、CAT 和 SOD 水平显著降低。与 CsA 处理组相比,给予 CC 治疗的 CSA 大鼠血清尿素和肌酐水平以及组织中 IL-2 和 MDA 水平显著降低。与 CsA 处理组相比,肾组织中 Gpx1、CAT 和 SOD 水平更高。与 CsA 处理相比,CC 处理减少了肾形态的恶化。本研究结果表明,CC 通过其抗炎和抗氧化作用可能预防 CSA 诱导的肾毒性。需要做更多的工作来确定 CC 改善作用的机制见解。